Impact of diabetes on 1‐year clinical outcome in patients undergoing revascularization with the BioFreedom stents or the Orsiro stents from the SORT OUT IX trial
Sign Up to like & getrecommendations! Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30090
Abstract: This sub‐study of the SORT OUT IX trial sought to compare clinical outcomes between patients with diabetes randomized to implantation of either the polymer‐free biolimus A9‐coated BioFreedom stent (BF‐BES) or the ultra‐thin strut, biodegradable polymer… read more here.
Keywords: patients diabetes; impact; sort trial; year ... See more keywords
TCT-290 Outcomes After Revascularization With a Polymer-Free Biolimus-Eluting BioFreedom Stent or a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Orsiro Stent in Patients With and Without Acute Coronary Syndromes: From the SORT OUT IX Trial
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2019.08.365
Abstract: In the SORT OUT IX trial, the biolimus A9-coated BioFreedom stent, a stainless steel drug-coated stent devoid of polymer (BF-BES), did not show noninferiority to the biodegradable polymer ultrathin strut sirolimus-eluting Orsiro stent (O-SES). The… read more here.
Keywords: sort trial; biofreedom stent; biodegradable polymer; polymer ... See more keywords